Dual Target CAR-T Cells in B-cell Lymphoma

Clinical trial NCT04723914 · UNKNOWN

Trial details

NCT number: NCT04723914
Sponsor: YuLi
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-Cell Relapse/Recurrence Refractory Lymphoma Dual-target CAR-T Cells

Start date: 2020-10-20
Primary completion: 2022-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.